Product Information

TIZANIDINE HCL 4 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.0885 per EA under NDC 00591278986. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Aug 29, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TIZANIDINE HCL 4 MG CAPSULE

tizanidine hydrochloride
$0.0885per EA

Strength

4 mg/1

NDC

00591278986

Classification

Generic

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TIZANIDINE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021447

FDA Approved

8/29/2002

TE Code

AB

On Market Since

2/6/2012

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for TIZANIDINE HCL 4 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 96.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0885 per EA
All-time high$2.6141 (Jul 16, 2014)
All-time low$0.0827 (May 22, 2024)
52-week high$0.1201
52-week low$0.0846
Median price$0.3960
Average price$0.8495
Largest weekly change+94.5% (Jun 23, 2021)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-3.4%

1M

-3.4%

3M

-3.6%

6M

+4.6%

1Y

-26.3%

3Y

-26.5%

5Y

-56.4%

All

-96.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TIZANIDINE HCL 4 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 4 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.0885 per EA (NDC 00591278986), effective Aug 19, 2026.

How has the price of TIZANIDINE HCL 4 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has declined 96.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 4 MG CAPSULE?

Since Nov 28, 2013, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has ranged from a low of $0.0827 (May 22, 2024) to a high of $2.6141 (Jul 16, 2014), with a median of $0.3960 per EA.

Are there cheaper alternatives to TIZANIDINE HCL 4 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TIZANIDINE HCL 4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TIZANIDINE HCL 4 MG CAPSULE?

TIZANIDINE HCL 4 MG CAPSULE (NDC 00591278986) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.